Member Info for MrIndia

Amazingly there are still some crazy people selling on the day of a game changing RNS. Each to there own as it looks like they are not interesting in making real money on the stock market

Thanks to JHFH who put up with my tantrums and guided me to stay here, this looks a solid multibagger in Q1 now. Well done HEMO in getting so so close to IND and I think all of us LTHs can now feel relaxed and the upside.

FOMO is about to kick in and these shares will be like gold dust as it approaches IND submission and approval in Feb / March. Combine that with CBR and possible work on the new covid (As per VLADs tweets), the $4m biodefence grant and CDX .. OMG its gonna be a good year to hold this stock to 10p and beyond

JHFH ... you really do know this stock and its timings and we all welcome your insight into next big news

All the cheap shares under 1.5p placing price being snapped up quickly ... This gets to 1.6p and with news imminent, it could be the multibagger we been waiting for. All those still waiting to buy cheaper, now is the last chance before the train and rocket start to move ... and this is with no coverage or RNS !!!

HFH ... Nicely put. I think the engines of the rocket are starting. Cmon vlad and hemo make it happen and lets put all the past behind us. Time for lift off !!!

JHFH ... I agree 100%. There are still some crazy sellers out there but limited in number. Either they dont know whats coming or just trying to drive the price down to do some short selling. Irrespective for all those people who are waiting for the RNS, its crazy since you will then be buying at a higher price !!!!

If only I had some spare cash, I would put it in here and leave it for 1 month and hope this allows me to gain 100% rather than a 2 or 3% people are playing with by selling out now.

Dhub ... I think this is the same seller that is offloading blocks of 500k every few weeks. Not sure he has that many left as its been going on for months now and the price is starting to find a bottom. He seems to sell around 1.35. The quicker we get some updates from hemo, the quicker this sad person will go away. The volume is so so low that its easy for them to manipulate every rise at will ... I really hope Vlad drops the RNS this week and destroys these shorters.

03-Jan-23 10:50:07 1.3434 500,000 Sell* 1.30 1.40 6,717 O

Looks like the sad seller is still out there trying to depress any rise. We really do need news on RUN2 so buyers flood in and his individual attempt at destroying sentiment is not accomplished. This should be flying on a day like today !!!!

This is great but am surprised this is not being pumped like every other covid stock !!! I really dont understand why we dont get the same love as others.

dhub ... I agree but predictions are useless with hemo. I also confident it is done and the RNS is coming but you never can be confident here based on the past. Hoping 2023 is a new start for hemo marketing and results beat expectations.

I am a little surprised that people are not taking some easy profits from the covid stocks into hemo and then letting this role over the next few weeks where we could see some real rises.

Dhub ... The markets are blue, pharma stocks are rocketing and lets hope some of that positivity and profits come from ABDX, GDR and Novacyt into HEMO soon as they seeing rises now of 20% consistently for last 4 days. I really hope one day we can see that sort of interest in hemo and not just us holders talking and dreaming of what if?.

HFH ... I am actually very happy that your response is super positive. Very different to your normal another week, no news email. I think you and JHFH have got it spot on ... we are about to turn the corner and now just await one bit of good news and this thing should get the attention it deserves. If RUN2 is successful, IND is nearly guaranteed and whether it is $50m or $300m MCAP, this is soooooo underrated its a joke

All we can do now is wait for hemo to step up and support its patient LTHs and produce the 1st of many RNS in January

Hello All and Happy new Years and lets hope it really is for HEMO in 2023.

I have seen some new people on here in the last few weeks which gives me hope there are many sitting in the background, with some good large investments and are just waiting for news. I looked back at 2022 and it does look like HEMO didnt do anything unforeseen or negative during the year. Nevertheless, they were battered again mainly because of the war, distrust in biotech and its high risk nature, some very bad dodgy traders who sold in volume and expectations being set very high by vlad and not really being met or exceeded. I do believe though we are still at the bottom and this is the best time to buy ... whats there to lose if the big seller has gone or will go and traders are just waiting to get in soon. I also repeat HFH list of things to come and hope hEMO marketing get this list and make sure they update us on progress ... if that happens, I dont even want to predict what the price could be in Q1 / Q2. I also give some prediction of dates based on what JHFH has said and a little wishful thinking :

2nd successful PQ run for CAR-T - Based on video, this is done and could be announced in the next week or 2
Results that CBR successfully works on killing live viruses - ?
3rd successful PQ run for CAR-T - Early Feb
CDX partner announced - This has been in discussion since March so something must be bubbling
CAR-T FDA IND application - March
Allocation of CBR $4m Biodefence grant - March
Start of CAR-T Clinical Trials - April

JHFH ... Lets ignore the past as we cannot change that. Vlad messed up and mistakes are made so lets say he is forgiven. He now has an amazing opportunity to change the way he is and make 2023 a big year for his investor base .... however small it is.

1) We all hope that he has got the $4m for the biotech fund but we cannot be sure
2) We all hope that CART will IND ready by March but based on past, he hasnt really met any deadlines and forget beating expectations
3) You have been saying the share will rerate but that ONLY happens if there is volume and new buyers. That happened with ABDX and Novacyt since they have real products in the market that can generate revenue and China covid has triggered that buying. Even with IND approval, this does not guarantee a rerate unless we get a wider investor base and that has always been the problem with hemo. Hardly any institutions or big buyers ... we see literally a few million shares traded on a good day and thats it
4) I know Vlad is frugal but tweets and videos dont make a reliable and trust worthy biotech company. What does is a regular update to the market and not just a couple of good mates on private ZOOM calls.

I am very confident that things have to change as well. I am desperate to see some more RNS and a wider investor base investing the money they put into other pharma and put it in here but it needs huge change of sentiment towards VLAD and that is the key item here ... if suddenly he announces something he has promised for years, this share will go ballistic but until then the dream of a rerate and this share being undervalued is what it will be

Sorry but what has he really done to steer the ship in the right direction as it couldnt get much worse. We still dont have any update on anything other than CART? We are all hoping that RUN2 is nearly complete and its only ok being 30% down if you bought late or had the money to average down. Most people are sitting on bigger losses for years and thats not a good investment

HT ... I think you are totally right on this one. He has continually suggested big things or news is close and then every week is the same ... nothing and people just lost faith in this ability to deliver anything. That is why the share price is around 1.3p, there are no real big investors willing to invest and it is easy to short this stock

I remember last xmas we were saying news is close and this will be a £1 stock. What a joke ... Our money has been dead in this stock for so long and just because Vlad says 95% of his money in this company, it doesnt mean anything. It just means he is hoping for success.

The company needs a real CEO that understands what markets need, what investors need and how to deliver on time and meet expectations. That will not change in 2023 as this man is here to stay and we just hope that he can lure some new buyers into this disgraceful stock. For me Q1 is make or break for this company

With Run1 completed and vlads tweet "exceeding expectations) and run2 news expected in a few weeks, I would hope that sentiment could not be better. Not sure where these BUYERS are going to come from since we have been waiting for them for years but 2022 would have been much better if not for the mass selling by the dodgy big sellers. I keep looking at the massive list of things to come that HFH put out and surely hemo could do better in marketing and updating the wider investment community on what the massive upside is for this stock.

pumpky ... why not put that money into hemo and pay for 3 holidays in jan or do you not believe a rerate is coming anytime soon?

Dhub ... A small rise last week of 7% and we all got excited that we might see a rerate. This week has been the usual stuff with hemo with hardly any volume and more sells than buys. I really cannot understand this stock and seeing Abingdon and Novacyt rise so much on no news and speculation about covid, makes it even stranger.

Why is there no volume here? Why are no new buyers coming in ready for a rerate in January?

is it because they dont believe news is imminent or believe it will be delayed again as has been the case for a long time. Its been a frustrating wait and we now await news on Run2. This really needs to come soon to create some impetus in this stock or we could still be here in March at the same price.

Low volume, few trades and lots of strange small buys. Looks like there are still some doubters out there selling off which is fine ... I just wish i had a little more to purchase now before the bounce again.

Dhub ... So a rerate to $50m by Feb and a rerate to $200m by April is possible just on CART ... this maybe wishful thinking but those are the comparisons I keep seeing for other pre-ind and post-ind applications. Whats not to like .... if all goes to plan and Vlads "Better than expected" quote becomes a reality